Metastatic Solid Tumors

Also known as: Solid Metastatic Tumor / Metastatic Solid Tumor / Metastatic Solid Neoplasm

DrugDrug NameDrug Description
DB11986EntrectinibEntrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment...
DB14723LarotrectinibA kinase inhibitor used to treat solid tumors with neurotrophic receptor tyrosine kinase gene fusion, are metastatic, high risk for surgery, or have no alternative treatments.
DB15685SelpercatinibA RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations.
DrugDrug NameTargetType
DB11986EntrectinibCytochrome P450 3A4enzyme
DB11986EntrectinibP-glycoprotein 1transporter
DB11986EntrectinibHigh affinity nerve growth factor receptortarget
DB11986EntrectinibBDNF/NT-3 growth factors receptortarget
DB11986EntrectinibNT-3 growth factor receptortarget
DB11986EntrectinibProto-oncogene tyrosine-protein kinase ROStarget
DB11986EntrectinibTyrosine-protein kinase JAK2target
DB11986EntrectinibActivated CDC42 kinase 1target
DB14723LarotrectinibCytochrome P450 3A4enzyme
DB14723LarotrectinibHigh affinity nerve growth factor receptortarget
DB14723LarotrectinibBDNF/NT-3 growth factors receptortarget
DB14723LarotrectinibNT-3 growth factor receptortarget
DB14723LarotrectinibP-glycoprotein 1transporter
DB14723LarotrectinibATP-binding cassette sub-family G member 2transporter
DB15685SelpercatinibProto-oncogene tyrosine-protein kinase receptor Rettarget
DB15685SelpercatinibVascular endothelial growth factor receptor 1target
DB15685SelpercatinibVascular endothelial growth factor receptor 3target
DB15685SelpercatinibFibroblast growth factor receptor 1target
DB15685SelpercatinibFibroblast growth factor receptor 2target
DB15685SelpercatinibFibroblast growth factor receptor 3target
DB15685SelpercatinibCytochrome P450 3A4enzyme
DB15685SelpercatinibCytochrome P450 2C8enzyme
DB15685SelpercatinibCytochrome P450 3A Subfamilyenzyme
DB15685SelpercatinibP-glycoprotein 1transporter
DB15685SelpercatinibATP-binding cassette sub-family G member 2transporter
DB15685SelpercatinibMultidrug and toxin extrusion protein 1transporter
DrugDrug NamePhaseStatusCount
DB17162ATG-1011Recruiting2
DB12565Abexinostat1Active Not Recruiting1
DB06013Aldoxorubicin1Completed1
DB12015Alpelisib1Completed1
DB17191Altiratinib1Terminated1
DB11595Atezolizumab1Recruiting4
DB11945Avelumab1Completed1
DB15399BMS-7548071Completed1
DB15387Bintrafusp alfa1Completed1
DB16668Budigalimab1Active Not Recruiting1
DB15286CB-11581Completed1
DB01101Capecitabine1Recruiting1
DB00958Carboplatin1Active Not Recruiting1
DB00958Carboplatin1Completed2
DB14707Cemiplimab1Recruiting1
DB00002Cetuximab1Active Not Recruiting1
DB05239Cobimetinib1Active Not Recruiting1
DB01394Colchicine1Recruiting1
DB00390Digoxin1Recruiting1
DB01248Docetaxel1Recruiting3
DB01248Docetaxel1Terminated1
DB11986Entrectinib1Completed1
DB00530Erlotinib1Completed1
DB14951Etirinotecan pegol1Completed1
DB00947Fulvestrant1Not Yet Recruiting1
DB17487GDC-19711Recruiting1
DB00441Gemcitabine1Completed2
DB00441Gemcitabine1Recruiting2
DB09257Gimeracil1Recruiting1
DB16479Inbakicept1Recruiting1
DB11886Infigratinib1Completed1
DB17467Interleukin-15, human recombinant1Recruiting1
DB06186Ipilimumab1Recruiting1
DB00762Irinotecan1Recruiting1
DB01006Letrozole1Not Yet Recruiting1
DB16828MK-22061Completed1
DB17424MVA-BN-brachyury-TRICOM vaccine1Completed1
DB00331Metformin1Recruiting1
DB11793Niraparib1Recruiting1
DB09035Nivolumab1Recruiting2
DB00338Omeprazole1Recruiting1
DB06306Onalespib1Completed1
DB03209Oteracil1Recruiting1
DB00526Oxaliplatin1Recruiting1
DB01229Paclitaxel1Active Not Recruiting1
DB01229Paclitaxel1Completed2
DB01229Paclitaxel1Recruiting2
DB06603Panobinostat1Active Not Recruiting1
DB06589Pazopanib1Active Not Recruiting1
DB09037Pembrolizumab1Not Yet Recruiting1
DB09037Pembrolizumab1Recruiting6
DB14904Pimasertib1Completed1
DB01132Pioglitazone1Completed1
DB18428RC1181Completed1
DB16826Repotrectinib1Recruiting1
DB16826Repotrectinib1Withdrawn1
DB15766Retifanlimab1Active Not Recruiting1
DB15766Retifanlimab1Completed1
DB01098Rosuvastatin1Recruiting1
DB17541SYNB18911Recruiting1
DB14935Serabelisib1Completed1
DB15569Sotorasib1Recruiting1
DB09256Tegafur1Recruiting1
DB14922Tislelizumab1Recruiting1
DB01030Topotecan1Completed1
DB15043Toripalimab1Recruiting1
DB12400Voxtalisib1Completed1
DB11176Zeaxanthin1Recruiting1
DB12638Zelavespib1Completed1
DB11967Binimetinib1 / 2Recruiting1
DB14707Cemiplimab1 / 2Active Not Recruiting1
DB00002Cetuximab1 / 2Active Not Recruiting1
DB17243GI-1011 / 2Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB17399JBI-8021 / 2Recruiting1
DB09078Lenvatinib1 / 2Recruiting1
DB12498Mogamulizumab1 / 2Completed1
DB17490NT-2191 / 2Active Not Recruiting1
DB18682NVL-6551 / 2Recruiting1
DB09035Nivolumab1 / 2Completed1
DB18289OBI-8881 / 2Terminated1
DB09074Olaparib1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting4
DB16826Repotrectinib1 / 2Recruiting3
DB16826Repotrectinib1 / 2Terminated1
DB15569Sotorasib1 / 2Recruiting1
DB15106Surufatinib1 / 2Active Not Recruiting1
DB11760Talazoparib1 / 2Recruiting1
DB00853Temozolomide1 / 2Recruiting1
DB14922Tislelizumab1 / 2Active Not Recruiting1
DB08911Trametinib1 / 2Recruiting1
DB08911Trametinib1 / 2Terminated1
DB17577Crefmirlimab2Completed1
DB00619Imatinib2Withdrawn1
DB12674Lurbinectedin2Completed1
DB09035Nivolumab2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB12893Sacituzumab govitecan2Active Not Recruiting1
DB11857Seribantumab2Active Not Recruiting1
DB00877Sirolimus2Recruiting1
DB00877Sirolimus2Terminated1
DB05773Trastuzumab emtansine2Recruiting1
DB11652Tucatinib2Recruiting1
DB12893Sacituzumab govitecan4Enrolling by Invitation1
DB06643DenosumabNot AvailableNot Yet Recruiting1